Drug-Diagnostics Co-Development in Oncology

The idea of combining drugs and diagnostics in oncology is not new. When the selective estrogen receptor modulator tamoxifen was developed in the 1970’s for the treatment of breast cancer a positive correlation between receptor status and treatment outcome was found. As a result of this research, it...

Descripció completa

Dades bibliogràfiques

Autor principal:	Jan Trost Jorgensen
Format:	Online
Idioma:	anglès
Publicat:	Frontiers Media SA 2021
Matèries:	R5-920 RM1-950 RC254-282 Q1-390 IHC fish precision medicine NGS Drug-diagnostic co-development companion diagnostics oncology personalized medicine thema EDItEUR::M Medicine and Nursing
Accés en línia:	18664
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!